<?xml version="1.0" encoding="UTF-8" standalone="no" ?>
<?xml-stylesheet href="drugsmodel.xsl" type="text/xsl" ?>
<model version='0.6' xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="drug.xsd">

  <!-- Drug history -->

  <history>
    <creator>
      <name>Miguel Schwander and Marc Flueckiger</name>
      <institution>HEIG-VD</institution>
      <email>marc.fluckiger@heig-vd.ch</email>
      <date>2014-06-06</date>
      <comments></comments>
    </creator>
    <revisions>
      <revision>
        <name>Miguel Schwander and Marc Flueckiger</name>
        <institution>HEIG-VD</institution>
        <email>marc.fluckiger@heig-vd.ch</email>
        <date>2014-06-06</date>
        <comments></comments>
      </revision>
    <revision>
        <name>Sylvain Goutelle</name>
        <institution>CHUV</institution>
        <email>sylvain.goutelle@chuv.ch</email>
        <date>2017-08-02</date>
        <comments><comment lang="en">
        Age range : 60-96 years
        Weight range.: 50-129
        Disease : Elderly patients with seizures (epilepsy)
        Drug formulation : immediate release
        </comment>
        </comments>
      </revision>
    </revisions>
  </history>

  <!-- Drug data -->

  <drug>

    <!-- Drug description -->

    <head>
      <atc>L01XE01</atc>
      <drugid>carbamazepine</drugid>
      <drugmodelid>ch.heig-vd.ezechiel.punyawudho_carbamazepine</drugmodelid>
      <!--Model extra because absorbsion constant k mean it is extra-->
      <pkmodelid>ezechiel.model.linear.1comp.extra.clv</pkmodelid>
      <drugnames>
        <name lang='en'>Carbamazepine</name>
        <name lang='fr'>Carbamazepine</name>
      </drugnames>
      <domainnames>
        <name lang='en'>Standard</name>
        <name lang='fr'>Standard</name>
      </domainnames>
      <studynames>
        <name lang='en'>Carbamazepine concentrations collected from 121 patients aged 60 years or older were used to develop a population pharmacokinetic model</name>
        <name lang='fr'>Concentrations de carbamazépine recueillies auprès de 121 patients âgés de 60 ans ou plus ont été utilisés pour développer un modèle pharmacocinétique de population</name>
      </studynames>
      <references></references>
      <descs>
        <desc lang='en'>...</desc>
        <desc lang='fr'>...</desc>
      </descs>
      <brands>
        <brand>Glivec</brand>
      </brands>
      <comments></comments>
    </head>

    <!-- Drug adme and intake -->

    <adme>
      <intake>extra</intake>
      <distribution>1</distribution>
      <elimination>linear</elimination>
      <comments></comments>
    </adme>

  <!-- Drug half-life -->

    <halflife>
      <unit>h</unit>
      <value>10</value>
      <multiplier>10</multiplier>
      <comments/>
    </halflife>


    <!-- Drug units and conversions -->

    <conversions>
      <units>
        <concentration>ug/ml</concentration>
        <result>ug/ml</result>
      </units>
      <factors>
        <concentration>0</concentration>
        <result>0</result>
      </factors>
      <molarmass>0</molarmass>
      <comments></comments>
    </conversions>

    <!-- Drug dosages -->

    <dosages>
      <doses default='200' unit='mg' any='false'>
        <dose>100</dose>
        <dose>200</dose>
        <dose>300</dose>
        <dose>400</dose>
        <dose>500</dose>
        <dose>600</dose>
      </doses>
      <intervals default='12' unit='h' any='false'>
        <interval>8</interval>
        <interval>12</interval>
        <interval>24</interval>
        <interval>48</interval>
      </intervals>
      <infusions default='0' unit='min' any='false'>
      </infusions>
      <comments>
      </comments>
    </dosages>

    <!-- Drug targets -->

    <targets>
      <target>
        <type>residual</type>
        <concentrations unit='ug/ml'>
          <min>
            <value>4</value>
            <formula></formula>
          </min>
          <max>
            <value>12</value>
            <formula></formula>
          </max>
          <best>
            <value>8</value>
            <formula></formula>
          </best>
        </concentrations>
        <comments>
        </comments>
      </target>
    </targets>

    <!-- Drug covariates -->

    <covariates>
      <covariate>
        <id>phenytoin</id>
        <names>
          <name lang='en'>Phenytoin</name>
          <name lang='fr'>Phenytoin</name>
        </names>
        <descs>
          <desc lang='en'>Phenytoin</desc>
          <desc lang='fr'>Phenytoin</desc>
        </descs>
        <unit></unit>
        <type>bool</type>
        <defaultvalue>0</defaultvalue>
        <comments></comments>
      </covariate>
    </covariates>

    <!-- Drug error model -->

    <errormodel>
      <additive>0</additive>
      <proportional>0.251</proportional>
      <comments>
      </comments>
    </errormodel>

    <!-- Drug parameters -->

    <parameters>
      <parameter>
        <id>CL</id>
        <unit>l/h</unit>
        <value>3.59</value>
        <bsv>
          <additive>0</additive>
          <proportional>0.181</proportional>
        </bsv>
        <min>0.001</min>
        <max>100000</max>
        <step>1</step>
        <comments></comments>
      </parameter>
      <parameter>
        <id>V</id>
        <unit>l</unit>
        <value>102</value>
        <bsv>
          <additive>0</additive>
          <proportional>0.747</proportional>
        </bsv>
        <min>0.1</min>
        <max>50000</max>
        <step>1</step>
        <comments></comments>
      </parameter>
      <parameter>
        <id>Ka</id>
        <unit>h-1</unit>
        <value>0.197</value>
        <bsv>
          <additive>0</additive>
          <proportional>0</proportional>
        </bsv>
        <min>0.01</min>
        <max>10</max>
        <step>1</step>
        <comments></comments>
      </parameter>
       <parameter>
        <id>F</id>
        <unit>%</unit>
        <value>0.8</value>
        <bsv>
          <additive>0</additive>
          <proportional>0</proportional>
        </bsv>
        <min>1</min>
        <max>1</max>
        <step>1</step>
        <comments><comment lang="fr">
				F estimée entre 75 et 85% d'après Patsalos et al Antiepileptic drugs best practice guidelines. Epilepsia 2008
        </comment>
        </comments>
      </parameter>
    </parameters>

    <!-- Drug correlations -->

    <correlations>
    </correlations>

    <!-- Drug operations -->

    <operations>
      <operation>
        <parameter>CL</parameter>
        <formula><![CDATA[
  theta1=parameter_CL;
  theta2 = 0.23;

if (covariate_phenytoin)
  PHEN=1;
else
  PHEN=0;

PHEN = covariate_phenytoin;

TVCL = theta1*(1+theta2*(PHEN));
return TVCL

        ]]></formula>
        <comments><comment lang="en">
        CL multiplied by 1.23 if Phenytoin co-administered
        </comment>
        </comments>
      </operation>
    </operations>
    <!-- Drug general comments -->

    <comments>
    </comments>

  </drug>
</model>
